PTC Therapeutics Inc header image

PTC Therapeutics Inc

PTCT

Equity

ISIN null / Valor 2515234

NASDAQ (2026-11-02)
USD 60.88+1.52%

PTC Therapeutics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

PTC Therapeutics, Inc. (NASDAQ: PTCT), headquartered in South Plainfield, New Jersey, is a biopharmaceutical company that develops and commercializes therapies for rare and genetic disorders, with a particular focus on neuromuscular and CNS diseases. The company pursues a mix of small-molecule and gene- and RNA-targeted approaches and markets products in select international territories; its best‑known marketed agent is ataluren (Translarna), approved in some jurisdictions for nonsense‑mutation Duchenne muscular dystrophy. PTC’s business model combines internal drug discovery and clinical development with commercial operations, licensing and partnerships to advance a pipeline aimed at other inherited disorders and rare diseases while generating revenue from product sales, royalties and collaborative agreements.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-10.9%1Y
237%3Y
52.8%5Y

Performance

40.7%1Y
54.0%3Y
55.8%5Y

Volatility

Market cap

5086 M

Market cap (USD)

Daily traded volume (Shares)

1,339,274

Daily traded volume (Shares)

1 day high/low

45.95 / 44.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Strides Pharma Science Ltd
Strides Pharma Science Ltd Strides Pharma Science Ltd Valor: 1071169
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.93%INR 1,037.80
Caplin Point Laboratories Limited
Caplin Point Laboratories Limited Caplin Point Laboratories Limited Valor: 34217236
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.56%INR 2,337.85
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%EUR 6.08
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%EUR 48.81
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG Carl Zeiss Meditec AG Valor: 1055489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%EUR 35.00
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.56%CHF 391.00
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.40%CHF 101.05
Divi's Laboratories Limited
Divi's Laboratories Limited Divi's Laboratories Limited Valor: 3132723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.42%INR 9,950.00
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.73%CHF 89.30
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.83%CHF 4.33